IPL's Q1 FY27 saw consolidated revenue drop 9.2% YoY to INR 256 Cr, with EBITDA at INR 39 Cr (15.4% margin) and PAT at INR 23 Cr.

Performance was impacted by subdued domestic demand, particularly for Pretilachlor, and higher costs.

Exports contributed INR 89 Cr, holding steady.

Management noted a challenging market due to erratic rains but remains confident in long-term growth by focusing on operational efficiency, cost management, and R&D. A significant milestone was EU Technical Equivalence approval for a fungicide, expected to add INR 30-40 Cr to annual export revenue from November.

IPL plans three new products for FY27, including a fungicide to substitute Chinese imports, aiming to diversify its portfolio.

The Hamirpur facility's herbicide block is a priority, targeting INR 50-60 Cr revenue this year, with a long-term potential of INR 1,000 Cr from 8-10 blocks over 3-4 years.

The company anticipates lower single-digit growth for FY27, with a target of ~18% sustainable EBITDA margins.